Skip to main content
Erschienen in: Journal of Robotic Surgery 2/2023

Open Access 16.10.2022 | Original Article

Robotic transanal excision of rectal lesions: expert perspective and literature review

verfasst von: Sarah Watanaskul, Marisa E. Schwab, Hueylan Chern, Madhulika Varma, Ankit Sarin

Erschienen in: Journal of Robotic Surgery | Ausgabe 2/2023

Abstract

Transanal excision of benign lesions, moderately or well-differentiated rectal T1 adenocarcinomas is typically completed via transanal endoscopic microsurgery (TEM) or laparoscopic transanal minimally invasive surgery (TAMIS). Robotic platforms provide ergonomic comfort in an enclosed space, enhanced range of motion, and superior 3D visualization. This study sought to perform a literature review of robotic TAMIS (R-TAMIS) and provide expert commentary on the technique. A Pubmed literature search was performed. Study design, robot type, indication, techniques compared, surgical margins, conversion, complications, operative time, estimated blood loss, patient positioning, and defect closure were collected from included articles. Expert opinion on pre-operative planning, technical details, and possible pitfalls was provided, with an accompanying video. Twelve articles published between 2013 and 2022 were included. Five were case reports, three case series, two prospective cohort studies, one retrospective cohort study, and one Phase II trial. The Da Vinci Si (n = 3), Xi (n = 2), single port (n = 3) and flex robotic system (n = 2) were used. Five studies reported negative surgical margins, one reported positive margins, and six did not comment. Operating room time ranged from 45 to 552 min and EBL ranged from 0 to 100 mL. Patient positioning varied based on lesion location but included supine, prone, modified lithotomy, and prone jackknife positions. 11/12 studies reported defect closure, most commonly with V-Loc absorbable suture. We recommend pre-operative MRI abdomen/pelvis, digital rectal exam, and rigid proctoscopy; prone jackknife patient positioning to avoid collisions with robotic arms; and defect closure of full-thickness excisions with backhanded running V-Loc suture.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Robotic surgery has become an increasingly popular tool for colorectal surgeons in the United States. A population-based study of Medicare beneficiaries from 2010 to 2016 showed an overall shift toward greater proportional use of robotic elective colectomy from 0.7% in 2010 to 10.9% in 2016 [1]. While the robotic approach has become common for surgeries such as colectomies and proctectomies, it remains a novel technique for transanal excision of rectal lesions. Rectal lesions amenable to transanal excision include benign lesions, small neuroendocrine tumors of the rectum, and rectal T1 adenocarcinomas that are moderately and well differentiated, (i.e. without lymphovascular or perineural invasion) [2].
These lesions have been traditionally excised by open technique if close to the anal verge or via transanal endoscopic microsurgery (TEM) or laparoscopic transanal minimally invasive surgery (TAMIS) if lesions are more proximal, but these methods are characterized by limited maneuverability and visualization. Robotic platforms offer several advantages for this surgery, including the ability to work in a small space with improved ergonomics and enhanced range of motion as well as superior 3D visualization [3, 4]. In a prior study [5], we compared robotic with laparoscopic TAMIS and traditional TEM, finding that all ten patients who underwent R-TAMIS procedures had negative surgical margins, as opposed to 10/13 in the TEM group and 5/6 in the TAMIS group. Furthermore, median operative times were lower for R-TAMIS (76 min) compared to TEM (110 min) and TAMIS (105 min).
In this study, we sought to review the literature on robotic TAMIS (R-TAMIS) for rectal lesions and provide practical tips and tricks for surgeons interested in adding this technique to their clinical repertoire.

Materials and methods

Literature review

An English language literature review was conducted in the PubMed database using combinations of the following search terms: “robot”, “transanal”, “rectal”, “excision”, “resection.” All robotic platforms were included in the search. This yielded 43 articles. After reading the abstracts, 13 articles of relevance were included. Two authors (SW, MS) independently reviewed the full manuscripts, and 11 articles were included. Studies pertaining to a different operation (such as abdominoperineal resection), review articles, and studies without human data were excluded. The references of the included articles were then reviewed to ensure no additional articles not captured in the PubMed search had been missed. Ultimately, 12 articles were included.
The following variables were available and reviewed from the included studies: study design, robot type, indication for resection, other techniques compared, surgical margins, conversion to other technique, complications, operative time, estimated blood loss (EBL), patient positioning, and whether the surgical defect was closed.

Expert perspective

A colorectal trained surgeon (AS) with 8 years of expertise in robotic surgery recorded a robotic transanal operation that illustrates the principles of this surgical technique (see linked video). A 63-year-old woman experiencing hematochezia was found to have a large rectal lesion on colonoscopy. This was diagnosed as a villous adenoma with low-grade dysplasia on biopsy. Pre-operative rigid proctoscopy located the lesion to the posterior wall at 8 cm from the anal verge, and she underwent a R-TAMIS procedure as shown. The final pathology was villous adenoma with high-grade dysplasia with negative surgical margins. She was discharged on post-operative day 1 and was doing well with no functional impairments at 1-month follow-up.
Expert opinion regarding pre-operative planning, intra-operative positioning and technical details, and possible pitfalls was provided.
The study was approved by the University of California San Francisco’s Institutional Review Board (IRB) Study Number 18-26,677.

Results

Literature review

Twelve articles published between 2013 and 2022 were included (Table 1). Of the included articles, five were case reports, three were case series, two were prospective cohort studies, one was a retrospective cohort study, and one was a Phase II clinical trial. Robotic platforms included the Da Vinci Si (n = 3), Da Vinci Xi (n = 2), Da Vinci single port (n = 3), and the flex robotic system (n = 2). One article compared patient outcomes from procedures with the Da Vinci Si versus flex robotic system, and another article did not specify which version of the Da Vinci system they used. The study sample size ranged from 1 to 26 patients, with a total of 114 pooled patients.
Table 1
Literature review
Author year
n
Study design
Robot
Indications
Conversion to other technique
Complications
OR time
EBL
Positioning
Defect closed
Morino 2022 [6]
26
Retrospective cohort
Flex robotic system
Benign adenoma, early rectal adenocarcinoma
TEO (n = 6)
Bleeding requiring transfusion (n = 2), local recurrence (n = 2)
Median: 115 min (range: 45–360)
Negligible
Supine (n = 16), Prone (n = 10)
Yes
Marks 2021 [7]
26
Phase II clinical trial
DV single port
Benign polyp, select rectal cancer (T1, < / = T2 after neoadjuvant therapy)
TEM (n = 2), laparoscopic low anterior resection (n = 1)
Pelvic abscess (n = 1), wound dehiscence (n = 3), peritoneal entry (n = 5)
Avg: 198.8 min (87–552)
Avg: 24.2 mL (range 0-185 mL)
Supine modified lithotomy (n = 25), prone (n = 1)
Yes
Studniarek 2021 [13]
1
Case report
DV single port
Rectal neuroendocrine tumor
No
Right lateral decubitus
Lo 2022 [11]
16
Case series
DV Xi
Tubulovillous adenoma, rectal adenocarcinoma
No
Incontinence (n = 1), presacral abscess (n = 1), rectal abscess (n = 1)
Avg: 87 min (IQR 54.75- 109.5)
Avg 17.5 mL (IQR 8.75-20 mL)
Lithotomy (n = 2), prone jackknife (n = 14)
Yes
Marks 2021 [9]
2
Case report
DV single-port
Endoscopically unresectable neoplastic polyps (serrated adenoma, tubulovillous adenoma)
No
None
Avg: 180.5 min (207, 154 min)
Avg: 15 mL (0, 30 mL)
Prone (n = 1), modified lithotomy (n = 1)
Yes
*Paull 2020 [8]
21
Case series
DV Si (n = 10), Flex robotic system (n = 11)
Early rectal neoplasia (T0-T1, N0)
Laparoscopic TAMIS (n = 3), transabdominal approach (n = 1)
DV Si: fractured mass (n = 1), proctotomy (n = 1). Flex: case aborted (n = 1)
DV Si: avg 167.6 ± 84.2 min (range 101–361)
Flex: 110.1 ± 39.9 min (range 55–180)
DV Si: avg 37.5 ± 38.3 mL (range 5–100)
Flex: 9.1 ± 13.6 mL (range 5–50)
Prone jackknife or high lithotomy for both DV Si and Flex
Yes
*Arnott 2018 [10]
10
Case series
DV S-type
Early stage rectal cancer (T0–T1, N0)
Laparoscopic TAMIS (n = 2), traditional TAE (n = 1), robotic abdominal approach (n = 1)
Rectal stenosis requiring dilation (n = 1), peritoneal entry (n = 1)
167 ± 26 min (101–361 min)
37.5 ± 11.6 mL (range 5–100 mL)
Lithotomy or prone jackknife
Yes
Ngu 2018 [18]
6
Prospective cohort
DV Xi
Locally advanced rectal carcinoma (cT3/4 ± N, 0 M) after neoadjuvant CRT
No
None
Median 106.5 min (range 69–217 min)
Minimal
Modified lithotomy
Yes
Paull 2018 [17]
1
Case report
Flex robotic system
Submucosal anterior mass, suggestive of GIST
No
None
Yes
Atallah 2014 [19]
1
Case report
DV Si
Poorly differentiated adenocarcinoma (pT1)
No
None
93 min
Negligible
Modified lithotomy with moderate Trendelenburg
Yes
Bardakcioglu 2013 [20]
1
Case report
DV
Recurrent rectal adenoma
No
None
Lithotomy
Yes
Buchs 2013 [12]
3
Prospective cohort
DV Si
Incomplete excision of T1 adenocarcinoma
No
Peritoneal entry (n = 1)
Mean 110 min (range 90–120 min, s.d. 17.3)
Mean 6.7 ± 2.9 mL
Left or right lateral position
Yes
*These studies contained overlapping datasets
DV Da Vinci, EBL estimated blood loss, TEO transanal endoscopic operation, TAMIS laparoscopic transanal minimally invasive surgery
For all 12 studies combined, indications for R-TAMIS included a benign adenoma or early rectal carcinoma that was unsuitable for endoscopic removal but eligible for local excision (n = 7/12); early-stage rectal cancer (T0-T1) that was not explicitly described as unsuitable for endoscopic removal (n = 4); and locally advanced rectal cancer (ranging from T0-T4) that was status post-treatment with chemoradiation therapy with clinical remission (n = 1). Final pathological diagnoses included benign adenoma, tubulovillous adenoma with or without high-grade dysplasia, villous adenoma, serrated adenoma, rectal adenocarcinoma, gastrointestinal stromal tumor (GIST), carcinoid tumor, and neuroendocrine tumor.
Four of 12 articles reported needing to convert from R-TAMIS to another technique, most commonly transanal endoscopic operation (TEO, n = 6), though TEM (n = 2) [6, 7], laparoscopic TAMIS (n = 3) [8], laparoscopic low anterior resection (n = 1) [9], and robotic transabdominal approaches (n = 1) [10] were also noted.
Upon removal of the mass, 7 of 12 studies reported negative surgical margins on histology, and only 1 study reported positive margins in 4/26 patients; however, 4 studies did not explicitly comment on surgical margins. Overall, 11 of 12 studies included final surgical pathology (Table 2), most of which was consistent with the pre-operative indication. One study [6] reported a change between pre-operative and post-operative pathology, namely that the pre-operative diagnosis of benign adenoma (n = 22/26) and early rectal adenocarcinoma (n = 4/26) turned out to be benign adenoma (n = 16/26) and rectal adenocarcinoma (n = 8/26) with two operations without histology-proven clear resection margins but patients had absence of residual disease.
Table 2
Final pathology details from literature review
Author year
n
Study design
Robot
Indications
Final pathology
Surgical margins
Morino 2022 [6]
26
Retrospective cohort
Flex robotic system
Benign adenoma (22/26), early rectal adenocarcinoma (4/26) unsuitable for endoscopic removal
Benign adenoma (16/26), early rectal adenocarcinoma (8/26), no histology-proven clear resection margins (2/26)
Positive (n = 4), Negative (n = 22)
Marks 2021 [7]
26
Phase II clinical trial
DV single port
Benign polyp (16/26), select rectal cancer (10/26) (T1, < / = T2 after neoadjuvant therapy) eligible for local excision
Adenocarcinoma (10/26) with T0 (n = 3), T1 (n = 3), T2 (n = 2), T3 (n = 1), T4 (n = 1). 7/10 received neoadjuvant chemotherapy; adenoma (14/26), GIST (1/26), carcinoid tumor (1/26)
Negative (n = 26)
Studniarek 2021 [13]
1
Case report
DV single port
Rectal neuroendocrine tumor
Rectal neuroendocrine tumor, grade 1 pT1aNxMx
Lo 2022 [11]
16
Case series
DV Xi
Endoscopically unresectable tubulovillous adenoma, rectal adenocarcinoma
Negative for tumor (4/16), tubulovillous adenoma (4/16), tubulovillous adenoma with high-grade dysplasia (4/16), invasive rectal adenocarcinoma (4/16)
Negative (n = 16)
Marks 2021 [9]
2
Case report
DV single-port
Endoscopically unresectable neoplastic polyps (serrated adenoma, tubulovillous adenoma)
Serrated adenoma (1/2) and tubulovillous adenoma (1/2)
Negative (n = 2)
*Paull 2020 [8]
21
Case series
DV Si (n = 10), Flex robotic system (n = 11)
Early rectal neoplasia (T0-T1, N0)
Neuroendocrine tumor (1/21), tubular adenoma (7/21), villous adenoma (1/21), tubulovillous polyp with adenomatous dysplasia (7/21), GIST (1/21), adenocarcinoma (4/21)
Negative (n = 20)
*Arnott 2018 [10]
10
Case series
DV S-type
Early stage rectal cancer (T0-T1, N0)
Neuroendocrine cells (1/10), tubular adenoma (3/10), tubulovillous/villous polyps with adenomatous dysplasia (4/10), adenocarcinoma (2/10)
Negative (n = 10)
Paull 2018 [17]
1
Case report
Flex robotic system
Submucosal anterior mass, suggestive of GIST
Low-grade GIST (1/1)
Ngu 2018 [18]
6
Prospective cohort
DV Xi
Locally advanced rectal carcinoma (cT3/4 ± N, 0 M) after neoadjuvant CRT
Atallah 2014 [19]
1
Case report
DV Si
Poorly differentiated adenocarcinoma (pT1)
Sessile serrated adenoma (1/1)
Buchs 2013 [12]
3
Prospective cohort
DV Si
Incomplete excision of T1 adenocarcinoma
T1 adenocarcinoma (3/3)
Negative (n = 3)
Bardakcioglu 2013 [20]
1
Case report
DV
Recurrent rectal adenoma
Villous adenoma without dysplasia (1/1)
Negative (n = 1)
DV Da Vinci, GIST gastrointestinal stromal tumor, CRT chemotherapy
Reported operating room time ranged from a minimum of 45 min to a maximum of 552 min, though median and mean times were around 100–200 min. Of the nine articles that commented on estimated blood loss, three listed EBL as minimal or negligible and the remaining six listed average values between 20 and 40 mL, with absolute ranges from a minimum of 0 mL to a maximum of 100 mL.
Patient positioning varied depending on the location of the lesion. Most studies reported supine, prone, modified lithotomy, or prone jackknife positioning. The supine position was preferred for posterior lesions, and the prone position for anterior lesions. Two studies opted for a left or right lateral decubitus position. 11 of 12 studies, regardless of whether the resection was submucosal or full-thickness, reported suturing the defect closed, most commonly with a 2-0 or 3-0 V-Loc absorbable suture; the remaining study did not explicitly comment on closing the defect.
All but one study detailed their post-operative complications. Pooled together, there were complications in 22/114 patients (19.3%). The listed complications included peritoneal entry (n = 7), pelvic or rectal abscess (n = 3), local recurrence (n = 2), bleeding requiring transfusions (n = 2), wound dehiscence (n = 1), incontinence (n = 1), fractured mass (n = 1), proctotomy (n = 1), case aborted (n = 1), and rectal stenosis requiring dilation (n = 1).
Most studies did not specifically comment on post-operative functional outcomes for patients. However, one study noted that no colostomies were needed [9]. Another identified one patient who developed post-operative incontinence at 2 weeks, but this resolved spontaneously after 1 month [11]. A third study described a patient who developed rectal stenosis requiring dilation within 2 months postoperatively after removal of a fragmented mass; this patient did not have evidence of disease recurrence at 6 months [8]. A fourth study included a patient whose procedure had a complication of pneumoperitoneum that was further investigated with exploratory laparoscopy; the patient did not have any post-operative complications and did not develop anal sphincter dysfunction at 2-month follow-up [12].

Discussion

The included studies described using various robotic platforms, including the Da Vinci Si, Da Vinci Xi, Da Vinci single port, and the flex robotic system. The Da Vinci single port (SP) is a relatively new robotic platform with a single 25-mm cannula that can include a surgeon-controlled 3D camera and three double-jointed articulated arms. The SP has 360-degree rotation of the robotic boom and instruments, thereby allowing access to all quadrants of the rectum without having to reposition the patient or the robot [7]. The SP also avoids external arm collision while working transanally [7, 13]. Having three arms available is advantageous since the third arm can be used for tissue retraction and applying suture tension during wound closure, and if it not needed, can be retracted into the cannula. A holographic navigation system present on the console screen allows the surgeon to monitor the position of up to three instruments. The primary limitations of the SP system are limited instrumentation (namely lack of stapler, suction, and vessel sealer) and a necessary 10-cm distance from the target in order to allow the SP robotic arms to deploy and be fully functional, which becomes challenging when operating on distal lesions [9]. The flex robotic system, which is a relatively new robotic platform featuring a flexible robotic endoscope with two working channels that can accommodate bending instruments (e.g., needle holders, grasping forceps, monopolar tipped or laser holder coagulation instruments), allows for comfortable maneuverability within a long and narrow structure like the colon. The system’s HD-3D visualization also enables a choice between performing an endoscopic submucosal dissection or a full-thickness excision. However, despite the dexterity of the tools, the authors of the study needed to convert to a standard transanal endoscopic operation about a quarter of the time, which the authors attribute to a learning phase and the need for further instrument improvement. The in-progress changes focus on augmenting the dexterity of the endoscope and flexible instruments as well as increasing the availability of different tools, such as a fenestrated grasper, self-adjusting needle holder, and a better endoscope-to-rectoscope seal to prevent air leaks [6].
Variables like patient positioning depended on location of the lesion. One study noted patients with posterior lesions were placed in a supine position while those with anterior lesions were placed in a prone position [6]. One study involving the Da Vinci Xi system at a single community center found patient positioning to be an advantage of a robotic approach over laparoscopic one [11]. While laparoscopic TAMIS becomes more challenging if the lesion is not located in the dependent position, the maneuverability of the robot arms allows access to the lesion regardless of which quadrant it is in. In addition, the primary surgeon preferred placing patients in prone jackknife since it allowed for a wider range of movement for the robotic arms [11]. In contrast, in another study using the da Vinci Xi, the authors were able to routinely place patients in modified lithotomy and docked the robot from the left side of the operating table. They did not experience any difficulty with achieving adequate working angles due to the intraluminal instrument articulation and dexterity [14].
Nearly all included studies had final pathology results consistent with pre-operative indications since patients had already undergone a biopsy and other workup prior to being offered R-TAMIS. A robotic approach allowed for not only improved visualization and surgeon ergonomics, but also access to larger, more proximal, and more complex lesions including circumferential lesions [11].
Since robotic transanal procedures are still in development, a clear approach that would be considered the gold standard is not yet defined. Therefore, we aim to provide a variety of perspectives on how to approach R-TAMIS via a combined literature review and the expertise of a high-volume academic surgeon.
All R-TAMIS procedures at our institution have been performed with the Da Vinci robotic surgical xi system (Intuitive Surgical, Inc., Sunnyvale, CA). This literature review highlights that other robotic platforms are being used to excise rectal lesions. Others have argued that the da Vinci SP single-port platform is a better modality for transanal surgery as it eliminates arm collisions and expands the limits of elbow articulation [15]. We have found that with proper patient and trocar positioning, the Da Vinci Xi platform works well and the Da Vinci SP platform is currently only FDA approved for Head and Neck Surgery and Urology.

Pre-operative planning

Patients are typically identified as having a rectal lesion on flexible sigmoidoscopy or colonoscopy. Pre-operative MRI abdomen/pelvis is helpful in determining the distance from the anal verge as well as potential invasion beyond the submucosa [16]. A digital rectal exam and rigid proctoscopy is also helpful in determining the location of the lesion. Moreover, the relationship of the anterior lesions to the middle valve of Houston on MRI is important as it corresponds anteriorly to the peritoneal reflection. If the lesion is above this reflection, a full-thickness resection could result in an intra-peritoneal defect. We recommend that the patient should undergo a mechanical bowel preparation with oral antibiotics (Neomycin, Flagyl) the day prior to surgery.

Operative setup

We recommend general anesthesia to enable full muscle relaxation and rectal insufflation. A urinary catheter is not necessary. A single dose of pre-operative antibiotic is given. The optimal position is often prone jackknife. Positioning the patient in prone jackknife prevents the patient’s legs from colliding with the robotic arms (Fig. 1). The GelPOINT path device (Applied Medical, Rancho Santa Margarita, CA, USA) is inserted transanally and sutured to the skin of the buttocks. The standard 8 mm da Vinci trocars are then placed through the GelPort (Fig. 2). A 5 mm AirSeal (CONMED Corporation, Utica, NY, USA) is also inserted, for insufflation and manual assistance by a bedside assistant. Use of the AirSeal helps maintain stable pneumoinsufflation of the rectum. The robot should be brought in from the patient’s side, so that direct access to the perineum in between the legs is still available for the surgeon or assistant (Fig. 3).

Surgical technique

Placing a Raytec proximal to the lesion prevents effluent from coming down. The rectal lesion should be positioned inferiorly on the screen if possible to optimize wrist movement. The lesion is circumferentially outlined with a 1 cm margin using electrocautery prior to resection (Fig. 4). A full-thickness resection maintaining the relationship of all the layers of the rectal wall is performed. The defect is then closed primarily. We prefer using a running 6-inch V-Loc (Medtronic, Minneapolis, MN) suture as it can prevent knot-related complications and reduce suturing time [17, 18]. We found backhand suturing to be the most ergonomic and efficient technique to take full-thickness bites. While bleeding is uncommon, if significant it can be controlled using the Vessel Sealer or Ligasure. The specimen is removed intact and marked with correct orientation for final pathology (Fig. 5). Leaving a drain is not necessary.

Post-operative care

Robotic TAMIS can typically be done as outpatient, with the patient going home on the day of surgery. All patients are seen in clinic at 2 weeks for follow-up, with further follow-up dependent on the final pathology.
In conclusion, we review the literature pertaining to robotic TAMIS and provide practical tips and tricks for surgeons interested in using the robot for these types of cases.

Declarations

Conflict of interest

Sarah Watanasakul, Hueylan Chern, and Madhulika Varma have no conflict of interest. Marisa Schwab’s spouse is an employee of Intuitive Surgical. Ankit Sarin has worked as a consultant to evaluate novel robotic platforms for several companies, including Noah Medical, Neptune Medical, and Ethicon.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Sheetz KH, Norton EC, Dimick JB, Regenbogen SE (2020) Perioperative outcomes and trends in the use of robotic colectomy for medicare beneficiaries from 2010 through 2016. JAMA Surg 155(1):41–49CrossRefPubMed Sheetz KH, Norton EC, Dimick JB, Regenbogen SE (2020) Perioperative outcomes and trends in the use of robotic colectomy for medicare beneficiaries from 2010 through 2016. JAMA Surg 155(1):41–49CrossRefPubMed
2.
Zurück zum Zitat Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD et al (2013) Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 56(5):535–550CrossRefPubMed Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD et al (2013) Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 56(5):535–550CrossRefPubMed
3.
Zurück zum Zitat Lo KW, Blitzer DN, Shoucair S, Lisle DM (2021) Robotic transanal minimally invasive surgery: a case series. Surg Endosc 36(1):793–799CrossRefPubMed Lo KW, Blitzer DN, Shoucair S, Lisle DM (2021) Robotic transanal minimally invasive surgery: a case series. Surg Endosc 36(1):793–799CrossRefPubMed
4.
Zurück zum Zitat Tomassi MJ, Taller J, Yuhan R, Ruan JH, Klaristenfeld DD (2019) Robotic transanal minimally invasive surgery for the excision of rectal neoplasia: clinical experience with 58 consecutive patients. Dis Colon Rectum 62(3):279–285CrossRefPubMed Tomassi MJ, Taller J, Yuhan R, Ruan JH, Klaristenfeld DD (2019) Robotic transanal minimally invasive surgery for the excision of rectal neoplasia: clinical experience with 58 consecutive patients. Dis Colon Rectum 62(3):279–285CrossRefPubMed
5.
Zurück zum Zitat Schwab MEHS, Watanaskul S, Chern H, Varma M, Sarin A (2022) Comparison of advanced techniques for local excision of rectal lesions: case series. BMC Surg 22(1):1–6CrossRef Schwab MEHS, Watanaskul S, Chern H, Varma M, Sarin A (2022) Comparison of advanced techniques for local excision of rectal lesions: case series. BMC Surg 22(1):1–6CrossRef
6.
Zurück zum Zitat Morino M, Forcignano E, Arezzo A (2022) Initial clinical experience with a novel flexible endoscopic robot for transanal surgery. Tech Coloproctol 26(4):301–308CrossRefPubMedPubMedCentral Morino M, Forcignano E, Arezzo A (2022) Initial clinical experience with a novel flexible endoscopic robot for transanal surgery. Tech Coloproctol 26(4):301–308CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Marks JH, Kunkel E, Salem JF, Martin C, Anderson B, Agarwal S (2021) First clinical experience with single-port robotic transanal minimally invasive surgery (SP rTAMIS) for benign rectal neoplasms. Tech Coloproctol 25(1):117–124CrossRefPubMed Marks JH, Kunkel E, Salem JF, Martin C, Anderson B, Agarwal S (2021) First clinical experience with single-port robotic transanal minimally invasive surgery (SP rTAMIS) for benign rectal neoplasms. Tech Coloproctol 25(1):117–124CrossRefPubMed
8.
Zurück zum Zitat Paull JO, Graham A, Parascandola SA, Hota S, Pudalov N, Arnott S et al (2020) The outcomes of two robotic platforms performing transanal minimally invasive surgery for rectal neoplasia: a case series of 21 patients. J Robot Surg 14(4):573–578CrossRefPubMed Paull JO, Graham A, Parascandola SA, Hota S, Pudalov N, Arnott S et al (2020) The outcomes of two robotic platforms performing transanal minimally invasive surgery for rectal neoplasia: a case series of 21 patients. J Robot Surg 14(4):573–578CrossRefPubMed
9.
Zurück zum Zitat Marks JH, Kunkel E, Salem JF, Martin CT, Anderson B, Agarwal S (2021) First clinical experience with single-port robotic transanal minimally invasive surgery: phase ii trial of the initial 26 cases. Dis Colon Rectum 64(8):1003–1013CrossRefPubMed Marks JH, Kunkel E, Salem JF, Martin CT, Anderson B, Agarwal S (2021) First clinical experience with single-port robotic transanal minimally invasive surgery: phase ii trial of the initial 26 cases. Dis Colon Rectum 64(8):1003–1013CrossRefPubMed
10.
Zurück zum Zitat Arnott S, Skancke M, Obias V (2018) Robotic transanal microsurgery for high early rectal neoplasia (T0–T1, N0 lesions), case series of 10 patients. Int J Med Robot 14(6):e1956CrossRefPubMed Arnott S, Skancke M, Obias V (2018) Robotic transanal microsurgery for high early rectal neoplasia (T0–T1, N0 lesions), case series of 10 patients. Int J Med Robot 14(6):e1956CrossRefPubMed
11.
Zurück zum Zitat Lo KW, Blitzer DN, Shoucair S, Lisle DM (2022) Robotic transanal minimally invasive surgery: a case series. Surg Endosc 36(1):793–799CrossRefPubMed Lo KW, Blitzer DN, Shoucair S, Lisle DM (2022) Robotic transanal minimally invasive surgery: a case series. Surg Endosc 36(1):793–799CrossRefPubMed
12.
Zurück zum Zitat Buchs NC, Pugin F, Volonte F, Hagen ME, Morel P, Ris F (2013) Robotic transanal endoscopic microsurgery: technical details for the lateral approach. Dis Colon Rectum 56(10):1194–1198CrossRefPubMed Buchs NC, Pugin F, Volonte F, Hagen ME, Morel P, Ris F (2013) Robotic transanal endoscopic microsurgery: technical details for the lateral approach. Dis Colon Rectum 56(10):1194–1198CrossRefPubMed
13.
Zurück zum Zitat Studniarek A, Pan J, Gantt G Jr, Mellgren A, Giulianotti PC, Nordenstam JF (2021) Single-port, robot-assisted transanal excision of rectal lesion. Dis Colon Rectum 64(2):e25CrossRefPubMed Studniarek A, Pan J, Gantt G Jr, Mellgren A, Giulianotti PC, Nordenstam JF (2021) Single-port, robot-assisted transanal excision of rectal lesion. Dis Colon Rectum 64(2):e25CrossRefPubMed
14.
Zurück zum Zitat Ngu JC, Kuo LJ, Kung CH, Chen CL, Kuo CC, Chang SW et al (2018) Robotic transanal minimally invasive surgery for rectal cancer after clinical complete response to neoadjuvant chemoradiation. Int J Med Robot 14(5):e1948CrossRefPubMed Ngu JC, Kuo LJ, Kung CH, Chen CL, Kuo CC, Chang SW et al (2018) Robotic transanal minimally invasive surgery for rectal cancer after clinical complete response to neoadjuvant chemoradiation. Int J Med Robot 14(5):e1948CrossRefPubMed
15.
Zurück zum Zitat Studniarek A, Ng M, Gantt G Jr, Shokouh-Amiri M, Mellgren A, Nordenstam J (2020) Robotic transanal excision of a large rectal polyp–a video vignette. Colorectal Dis 22(11):1810–1811CrossRefPubMed Studniarek A, Ng M, Gantt G Jr, Shokouh-Amiri M, Mellgren A, Nordenstam J (2020) Robotic transanal excision of a large rectal polyp–a video vignette. Colorectal Dis 22(11):1810–1811CrossRefPubMed
17.
Zurück zum Zitat Fouda UM, Elsetohy KA, Elshaer HS (2016) Barbed versus conventional suture: a randomized trial for suturing the endometrioma bed after laparoscopic excision of ovarian endometrioma. J Minim Invasive Gynecol 23(6):962–968CrossRefPubMed Fouda UM, Elsetohy KA, Elshaer HS (2016) Barbed versus conventional suture: a randomized trial for suturing the endometrioma bed after laparoscopic excision of ovarian endometrioma. J Minim Invasive Gynecol 23(6):962–968CrossRefPubMed
18.
Zurück zum Zitat Krishnamoorthy B, Shepherd N, Critchley WR, Nair J, Devan N, Nasir A et al (2016) A randomized study comparing traditional monofilament knotted sutures with barbed knotless sutures for donor leg wound closure in coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 22(2):161–167CrossRefPubMed Krishnamoorthy B, Shepherd N, Critchley WR, Nair J, Devan N, Nasir A et al (2016) A randomized study comparing traditional monofilament knotted sutures with barbed knotless sutures for donor leg wound closure in coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 22(2):161–167CrossRefPubMed
Metadaten
Titel
Robotic transanal excision of rectal lesions: expert perspective and literature review
verfasst von
Sarah Watanaskul
Marisa E. Schwab
Hueylan Chern
Madhulika Varma
Ankit Sarin
Publikationsdatum
16.10.2022
Verlag
Springer London
Erschienen in
Journal of Robotic Surgery / Ausgabe 2/2023
Print ISSN: 1863-2483
Elektronische ISSN: 1863-2491
DOI
https://doi.org/10.1007/s11701-022-01469-8

Weitere Artikel der Ausgabe 2/2023

Journal of Robotic Surgery 2/2023 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.